HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

North Falmouth, MA

26 Edgerton Drive
Suite A
North Falmouth MA 02556

mon-fri9:00 AM - 5:00 PM

saturdayClosed

sundayClosed

Cancer Treatment Center in

North Falmouth, MA

Regional Cancer Care Associates of North Falmouth, MA, provides quality and compassionate cancer treatment and infusions for all our patients. We work closely with local hospitals to establish a comprehensive treatment plan to help effectively treat your condition. Our qualified physicians and hematologists will be with you and your caregivers every step of the way.

Our convenient North Falmouth location is on beautiful Cape Cod and is close to Bourne Bridge for easy access. With six exam rooms and a large infusion room with nine treatment chairs, we have the space and knowledge needed to provide standard oncology infusions and infusions for iron deficiency anemia, osteoporosis, and certain autoimmune and inflammatory conditions.

Cancer Treatment Services We Provide

Whether you’re dealing with cancer or an autoimmune or blood disorder, our experienced team is here for you. We’ll work to develop a clear understanding of your diagnosis, symptoms, and medical history to create a customized treatment plan. Our collaboration with Boston-area hospitals helps us provide our patients with the high-quality medical care they deserve.

OUR CANCER TREATMENT SERVICES INCLUDE:

To learn more about our services, contact us today.

Physicians in North Falmouth, MA

Our North Falmouth location has three experienced and highly trained doctors to assist you with your medical needs.

Victor Aviles, MD

Dr. Aviles is board-certified in Internal Medicine and Medical Oncology and serves as Chief of Hematology and Oncology at Falmouth Hospital and Consultant in Medicine at Massachusetts General Hospital. After earning his Bachelor of Arts in Health and Society at Brown University, he attended Washington University School of Medicine. After graduation, he went on to the University of Pennsylvania, where he completed his internship, residency, and fellowship. He is a member of the American Society of Clinical Oncology and the Massachusetts Society of Clinical Oncology.

Hannah Yamin, DO

Dr. Yamin is board-certified in Hematology, Internal Medicine, and Medical Oncology and is a member of the American Society of Clinical Oncology. She attended Saint Michael’s College, where she earned her Bachelor of Science degree in Biology and minored in Mathematics. After graduating, she attended the University of New England College of Osteopathic Medicine and completed her internship and residency at Roger Williams Medical Center. She completed her fellowship at the combined Brown University/RWMC program and currently lives in Sandwich with her husband and two children.

Jaffar Hilli, MD

Dr. Hilli is board-certified in Hematology, Internal Medicine, and Medical Oncology. He is also a professional member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association.

After graduating from Al-Mustansir University, College of Medicine in Baghdad, he completed his residency at Baghdad Teaching Hospital in the Department of Internal Medicine. He continued his medical education after immigrating to the United States, completing his residency in Internal Medicine at Brookdale University Medical Center.

He served as an associate program director in the Emergency Medicine Department at BUMC and then moved to Massachusetts. He completed his fellowship in Hematology and Medical Oncology at the University of Missouri, where he became a faculty member and served as the Associate Program Director. Eventually, he found his way back to Massachusetts to serve as the Medical Director at the Good Samaritan Medical Center in Brockton.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.